Thursday, August 17, 2017 6:06:22 AM
True, VPOR does not sell Cannabis specific products that would be restricted by Schedule I classification or Federal Law restrictions , but simply because they sell products that are ancillary to the cannabis market, like CBD & vape products (which are also used for cannabis) and the EG, they are viewed as being in, or on the fringe of the MJ sector by many traditional funding sources and as such, very risky to do business with. I know that because I do business with a great many of those traditional sources and they wrestle with this topic every day.
Although some traditional sources of funding are legally available to VPOR, these same lending sources choose who to do business with, and so far they choose not to do business with a company like VPOR. That is why I said that VPOR is subject to the same financial burdens and obstacles now that companies in the MJ sector are.
On a positive front, because they are on the fringe... as political, public and investment sentiment changes to reflect the growing MJ sector and opportunities therein, VPOR could well be one of those companies that traditional investors turn to first.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM